| Entry |
|
| Name |
Dipivefrin hydrochloride (USP); Dipivefrine hydrochloride (JAN); Propine (TN) |
| Formula |
C19H29NO5. HCl
|
| Exact mass |
387.1813
|
| Mol weight |
387.8982
|
| Structure |

|
| Simcomp |
|
| Class |
Cardiovascular agent
DG01456 Adrenergic receptor agonist
DG01951 Catecholamine adrenergic receptor agonist
Ophthalmic agent
DG03201 Intraocular pressure lowering agent
|
| Remark |
| Therapeutic category: | 1311 |
| Chemical structure group: | DG01129 |
| Product (DG01129): | D01017<JP> |
|
| Efficacy |
Antiglaucoma, Adrenergic receptor agonist |
| Comment |
Active form of prodrug: Adrenaline (Epinephrine) [DR:D00095]
Catecholamine derivative
|
| Target |
ADRA1 [HSA:148 147 146] [KO:K04135 K04136 K04137] ADRA2 [HSA:150 151 152] [KO:K04138 K04139 K04140] ADRB [HSA:153 154 155] [KO:K04141 K04142 K04143] |
| Pathway |
| hsa04080 | Neuroactive ligand-receptor interaction |
| hsa04270 | Vascular smooth muscle contraction |
|
| Interaction |
|
| Structure map |
| map07054 | Antiglaucoma agents |
|
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
S SENSORY ORGANS
S01 OPHTHALMOLOGICALS
S01E ANTIGLAUCOMA PREPARATIONS AND MIOTICS
S01EA Sympathomimetics in glaucoma therapy
S01EA02 Dipivefrine
D01017 Dipivefrin hydrochloride (USP) <JP>
Therapeutic category of drugs in Japan [BR:br08301]
1 Agents affecting nervous system and sensory organs
13 Agents affecting sensory organs
131 Ophthalmic agents
1311 Mydriatic agents
D01017 Dipivefrin hydrochloride (USP); Dipivefrine hydrochloride (JAN)
Drug groups [BR:br08330]
Cardiovascular agent
DG01456 Adrenergic receptor agonist
DG01129 Dipivefrine
D01017 Dipivefrin hydrochloride
DG01951 Catecholamine adrenergic receptor agonist
DG01129 Dipivefrine
D01017 Dipivefrin hydrochloride
Ophthalmic agent
DG03201 Intraocular pressure lowering agent
DG01129 Dipivefrine
D01017 Dipivefrin hydrochloride
Drug classes [BR:br08332]
Ophthalmic agent
DG03201 Intraocular pressure lowering agent
D01017 Dipivefrin hydrochloride
Target-based classification of drugs [BR:br08310]
G Protein-coupled receptors
Rhodopsin family
Adrenaline
ADRA1
D01017 Dipivefrin hydrochloride (USP) <JP>
ADRA2
D01017 Dipivefrin hydrochloride (USP) <JP>
ADRB
D01017 Dipivefrin hydrochloride (USP) <JP>
Prodrugs [br08324.html]
D01017
Drug groups [BR:br08330]
Cardiovascular agent
DG01456 Adrenergic receptor agonist
DG01129 Dipivefrine
DG01951 Catecholamine adrenergic receptor agonist
DG01129 Dipivefrine
Ophthalmic agent
DG03201 Intraocular pressure lowering agent
DG01129 Dipivefrine
Prodrugs [br08324.html]
DG01129
|
| Other DBs |
|
| KCF data |
ATOM 26
1 X Cl 21.9800 -26.1800
2 C8y C 15.1900 -20.7900
3 C8y C 15.1900 -22.1900
4 C8x C 16.3800 -22.8900
5 C8x C 17.6400 -22.1900
6 C8y C 17.6400 -20.7900
7 C8x C 16.3800 -20.0900
8 O7a O 14.0000 -20.0900
9 O7a O 14.0000 -22.8900
10 C1c C 18.8300 -20.0900
11 C1b C 20.0200 -20.7900
12 O1a O 18.8300 -18.6900
13 N1b N 21.2381 -20.0999
14 C1a C 22.4195 -20.7950
15 C7a C 14.0114 -18.6900
16 C7a C 14.0000 -24.2900
17 C1d C 12.7876 -24.9900
18 O6a O 15.2124 -24.9900
19 O6a O 15.2208 -18.0048
20 C1d C 12.7962 -17.9752
21 C1a C 11.5824 -18.6630
22 C1a C 12.8076 -16.5900
23 C1a C 11.6062 -17.2753
24 C1a C 11.5921 -24.2996
25 C1a C 12.7875 -26.3898
26 C1a C 11.5920 -25.6803
BOND 25
1 2 3 2
2 3 4 1
3 4 5 2
4 5 6 1
5 6 7 2
6 2 7 1
7 2 8 1
8 3 9 1
9 6 10 1
10 10 11 1
11 10 12 1
12 11 13 1
13 13 14 1
14 8 15 1
15 9 16 1
16 16 17 1
17 16 18 2
18 15 19 2
19 15 20 1
20 20 21 1
21 20 22 1
22 20 23 1
23 17 24 1
24 17 25 1
25 17 26 1
|